medigraphic.com

2021, Number 1

Rev Mex Anest 2021; 44 (1)

Anesthetic management in Steinert's disease: case report

Molero-Díez YB, Sánchez-Hernando VJ, Ruiz-Simón FA, Gómez-Fernández M, Mateos-Arribas MT, García-Lázaro F

Language: Spanish
References: 9
Page: 66-69
PDF size: 186.43 Kb.


ABSTRACT

A 60-year-old man with prostatic hypertrophy was scheduled for transurethral resection of the prostate. Steinert's disease and implantation of a pacemaker were his previous pathology. Being Steinert's disease the most relevant clinical characteristic and the type of intervention urologist has planned, we decide locoregional anesthesia technique, avoiding the potential complications that these patients may present with general anesthesia. The anesthetic management of Steinert's disease patients is a challenge for the anesthesiologist both due to the large number of complications that may appear during intra- and postoperative time as well as the low frequency of this pathology. In addition, surgical stress and the techniques we use can interfere with the course of the disease. Therefore, the approach and immediate intra-and postoperative care should be carefully planned and selected in order to obtain the best results and maximize patient safety.


REFERENCES

  1. Thornton CA. Myotonic dystrophy. Neurol Clin. 2014;32:705-719. Available in: http://doi.org/10.1016/j.ncl.2014.04.011

  2. Bird TD. Myotonic dystrophy type 1. In GeneReviews® [Internet]: University of Washington, Seattle; 2018. Available in: https://www.ncbi.nlm.nih.gov/books/NBK1165/

  3. Gutiérrez GG, Díaz-Manera J, Almendrote M, Azriel S, Bárcena JE, García PC, et al. Guía clínica para el diagnóstico y seguimiento de la distrofia miotónica tipo 1, DM1 o enfermedad de Steinert. Med Clin (Barc). 2019;153:82.e1-82.e17. Disponible en: http://doi.org/10.1016/j.medcli.2018.10.028

  4. Pelargonio G, Russo AD, Sanna T, De Martino G, Bellocci F. Myotonic dystrophy and the heart. Heart. 2002;88:665-670. Available in: http://dx.doi.org/10.1136/heart.88.6.665

  5. Bellini M, Biagi S, Stasi C, Costa F, Mumolo MG, Ricchiuti A, et al. Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol. 2006;12:1821. Available in: https://doi.org/10.3748/wjg.v12.i12.1821

  6. Hawkins AM, Hawkins CL, Abdul Razak K, Khoo TK, Tran K, Jackson RV. Respiratory dysfunction in myotonic dystrophy type 1: A systematic review. Neuromuscul Disord. 2019;29:198-212. Available in: https://doi.org/10.1016/j.nmd.2018.12.002

  7. Kerstin H. Recomendaciones para anestesia en pacientes que afectados por distrofia miotónica 1 y 2. Enciclopedia de Orphanet. 2014 [13/03/2019]. Disponible en: https://www.orpha.net/data/patho/Pro/es/Distrofia-miotonica-1-y-2_ES.pdf.

  8. Oriol-López S, Hernández-Bernal C. Anestesia en la distrofia muscular de Steinert. Rev Mex Anest. 2010;33:160-165.

  9. Catena V, Del Monte DD, Rubini A, Guccione C, Ricagna F, Gangeri G, et al. Anesthesia and myotonic dystrophy (Steinert's syndrome). The role of total intravenous anesthesia with propofol, cisatracurium and remifentanyl. Case report. Minerva Anestesiol. 2007;73:475-479.




2020     |     www.medigraphic.com